These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 16428155

  • 21. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.
    Rich P, Houpt KR, LaMarca A, Loven KH, Marbury TC, Matheson R, Miller B, Smith S, Wolf J, Tinea Corporis/Tinea Cruris Research Group.
    Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330
    [Abstract] [Full Text] [Related]

  • 22. Tinea corporis/cruris: new treatment options.
    van Heerden JS, Vismer HF.
    Dermatology; 1997 Jul; 194 Suppl 1():14-8. PubMed ID: 9154395
    [Abstract] [Full Text] [Related]

  • 23. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
    Jegasothy BV, Pakes GE.
    Clin Ther; 1991 Jul; 13(1):126-41. PubMed ID: 2029718
    [Abstract] [Full Text] [Related]

  • 24. What is the best way to treat tinea cruris?
    Nadalo D, Montoya C, Hunter-Smith D.
    J Fam Pract; 2006 Mar; 55(3):256-8. PubMed ID: 16510062
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study.
    Chatterjee D, Ghosh SK, Sen S, Sarkar S, Hazra A, De R.
    Indian J Pharmacol; 2016 Mar; 48(6):659-664. PubMed ID: 28066103
    [Abstract] [Full Text] [Related]

  • 26. Butenafine.
    McNeely W, Spencer CM.
    Drugs; 1998 Mar; 55(3):405-12; discussion 413. PubMed ID: 9530545
    [Abstract] [Full Text] [Related]

  • 27. Topical butenafine for tinea pedis.
    Med Lett Drugs Ther; 1997 Jul 04; 39(1004):63-4. PubMed ID: 9217695
    [No Abstract] [Full Text] [Related]

  • 28. Clotrimazole vs haloprogin treatment of tinea cruris.
    VanDersarl JV, Sheppard RH.
    Arch Dermatol; 1977 Sep 04; 113(9):1233-5. PubMed ID: 578400
    [Abstract] [Full Text] [Related]

  • 29. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study.
    Watanabe S, Takahashi H, Nishikawa T, Takiuchi I, Higashi N, Nishimoto K, Kagawa S, Yamaguchi H, Ogawa H.
    Mycoses; 2007 Jan 04; 50(1):35-40. PubMed ID: 17302746
    [Abstract] [Full Text] [Related]

  • 30. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis.
    Reyes BA, Beutner KR, Cullen SI, Rosen T, Shupack JL, Weinstein MB.
    Int J Dermatol; 1998 Jun 04; 37(6):450-3. PubMed ID: 9646136
    [No Abstract] [Full Text] [Related]

  • 31. Double-blind investigation of R-42470 (terconazole cream 0.4%) and clotrimazole (cream 1%) for the topical treatment of mycotic vaginitis.
    Del Palacio-Hernanz A, Sanz-Sanz F, Rodriquez-Noriega A.
    Chemioterapia; 1984 Jun 04; 3(3):192-5. PubMed ID: 6529776
    [Abstract] [Full Text] [Related]

  • 32. Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole.
    Patel A, Brookman SD, Bullen MU, Marley J, Ellis DH, Williams T, Barnetson RS.
    Australas J Dermatol; 1999 Nov 04; 40(4):197-200. PubMed ID: 10570555
    [Abstract] [Full Text] [Related]

  • 33. Comparative study of tioconazole and clotrimazole in the treatment of tinea versicolor.
    Alchorne MM, Paschoalick RC, Forjaz MH.
    Clin Ther; 1987 Nov 04; 9(4):360-7. PubMed ID: 3607817
    [Abstract] [Full Text] [Related]

  • 34. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
    Kjaeldgaard A.
    Pharmatherapeutica; 1986 Nov 04; 4(8):525-31. PubMed ID: 3520601
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
    Gupta AK, Skinner AR, Cooper EA.
    Int J Dermatol; 2005 Jul 04; 44(7):590-3. PubMed ID: 15985032
    [Abstract] [Full Text] [Related]

  • 36. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
    Zaitz C, Ruiz LR, Drullis EM, Gurfinkel P, Ciarnuto MA.
    Rev Inst Med Trop Sao Paulo; 1990 Jul 04; 32(4):299-303. PubMed ID: 1966257
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of 250 mg versus 500 mg oral terbinafine in the treatment of tinea corporis and cruris: A randomised, assessor-blinded comparative study.
    Lal NR, Basu D, Saha A, Ghosh R, Verma R, Bandyopadhyay D.
    Indian J Dermatol Venereol Leprol; 2023 Jul 04; 89(5):665-671. PubMed ID: 36688883
    [Abstract] [Full Text] [Related]

  • 38. Clinical evaluation of clotrimazole. A broad-spectrum antifungal agent.
    Spiekermann PH, Young MD.
    Arch Dermatol; 1976 Mar 04; 112(3):350-2. PubMed ID: 769697
    [Abstract] [Full Text] [Related]

  • 39. Topical treatment of common superficial tinea infections.
    Weinstein A, Berman B.
    Am Fam Physician; 2002 May 15; 65(10):2095-102. PubMed ID: 12046779
    [Abstract] [Full Text] [Related]

  • 40. Butenafine and superficial mycoses: current status.
    Singal A.
    Expert Opin Drug Metab Toxicol; 2008 Jul 15; 4(7):999-1005. PubMed ID: 18624686
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.